Assessing Pseudomonas virulence using mammalian models: acute infection model

Antje Munder1, Burkhard Tümmler

  • 1Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany, munder.antje@mh-hannover.de.

Insights

This study details a mouse model for Pseudomonas aeruginosa lung infections, tracking key health and bacterial metrics. The model effectively classifies bacterial virulence and mouse susceptibility, aiding preclinical drug development.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Animal Models

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen causing severe lung infections.
  • Accurate models are crucial for understanding P. aeruginosa pathogenesis and developing treatments.
  • Existing models may not capture the full spectrum of infection dynamics.

Purpose of the Study:

  • To establish and validate a comprehensive acute murine lung infection model for P. aeruginosa.
  • To enable robust classification of bacterial virulence and host susceptibility.
  • To support preclinical evaluation of anti-pseudomonal strategies.

Main Methods:

  • Intratracheal or intranasal inoculation of P. aeruginosa in mice.
  • Monitoring of continuous parameters: spirometry, rectal temperature, weight loss.
  • Endpoint assessments: body condition score, lung bacterial load, organ dissemination, lung inflammation scoring.

Main Results:

  • The model provides detailed characterization of infection progression.
  • It allows for reliable differentiation of P. aeruginosa strain virulence.
  • Host susceptibility in different mouse strains can be effectively assessed.

Conclusions:

  • The standardized acute murine lung infection model is a valuable tool for P. aeruginosa research.
  • It facilitates the preclinical assessment of novel prevention and intervention strategies.
  • This model aids in the development of new therapies against P. aeruginosa infections.

Related Concept Videos